Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Crinetics Pharmaceuticals is a clinical-stage biotech focused on developing oral, nonpeptide therapeutics targeting peptide GPCRs for endocrine diseases and tumors. Its pipeline includes treatments for acromegaly, carcinoid syndrome, and other hormonal disorders, emphasizing improved efficacy, safety, and patient convenience. The company leverages expertise in endocrine pathways, with proprietary molecules designed to address unmet medical needs in endocrinology and oncology markets.
This description was generated via AI from an annual report. Updated about 1 year ago.